Analysis of the Determinants of Adherence to Coadministration of Flu Vaccination With the Booster of COVID-19 Vaccine
NCT05781191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8231
Last updated 2024-03-18
Summary
This study investigates healthcare workers' attitudes towards co-administering COVID-19 and seasonal influenza vaccines, a method supported globally for its efficiency and potential to lessen healthcare burdens. It explores various factors affecting workers' willingness to accept or decline this approach, ranging from demographic to logistical aspects, and examines the link between vaccine hesitancy and co-administration acceptance, aiming to identify and address hesitancy towards both vaccines
Conditions
Interventions
- BIOLOGICAL
-
Booster (3rd) dose of COMIRNATY Seasonal dose of influenza vaccination based on patient's individual risk factors
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Patrizia Laurenti, MD · Fondazione Policlinico Universitario A. Gemelli IRCCS - Rome
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-13
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
- FDA Drug
- Yes
Countries
- Italy
Study Locations
More Related Trials
-
Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses
NCT06824779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
NCT06821061 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Herd Immunity and Influenza Vaccine Uptake
NCT03748160 ·Status: COMPLETED ·Phase: NA
-
A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults
NCT05091307 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers
NCT06831786 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Immune Responses in Health Care Personnel
NCT03323112 ·Status: RECRUITING
-
Systems Biological Assessment of Statin Effect on Vaccine Responses
NCT06024096 ·Status: COMPLETED ·Phase: PHASE4
-
Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians
NCT04706143 ·Status: UNKNOWN
-
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
NCT05970887 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults
NCT03160118 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations
NCT06020118 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.
NCT01063608 ·Status: COMPLETED ·Phase: PHASE4
-
Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease
NCT06030739 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
NCT03061955 ·Status: COMPLETED
-
Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects
NCT00311480 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
NCT00992212 ·Status: COMPLETED ·Phase: PHASE2
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
NCT05832307 ·Status: RECRUITING ·Phase: NA
-
Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake
NCT05542004 ·Status: COMPLETED ·Phase: NA
-
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)
NCT01910519 ·Status: COMPLETED ·Phase: PHASE2
-
A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains
NCT01416597 ·Status: COMPLETED
-
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 ·Status: COMPLETED
-
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
NCT05160636 ·Status: ACTIVE_NOT_RECRUITING
-
Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome
NCT06304038 ·Status: COMPLETED